Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Pfizer Fourth Quarter 2025 Earnings Call - VESPER-3 Validates PF-3944 Monthly GLP-1, Bolstering Obesity Platform
Pfizer closed 2025 with solid execution, beating adjusted EPS expectations and reaffirming 2026 guidance while navigating a sharp decline in COVID product revenue. The company reported FY revenues of ...
- VESPER-3 (PF-3944) met its two objectives: maintained robust weight loss switching from weekly to monthly dosing, and showed a favorable safety/tolerability profile when switching to a fourfold monthly dose.
- Week 28 placebo-adjusted weight loss in VESPER-3 was 10% for the low monthly dose and 12.3% for the medium monthly dose; model-based projections forecast ~16% placebo-adjusted loss for the planned high 9.6 mg monthly equivalent.
- VESPER-3 tolerability was comparable across weekly and monthly phases, predominantly mild to moderate GI adverse events, with only one instance each of severe nausea and vomiting across groups; no severe diarrhea reported and discontinuation rates were similar between phases.
- +13 more takeaways
Graphic Packaging Q4 2025 Earnings Call - CEO Prioritizes Inventory Cuts, $700-$800M 2026 FCF and $500M Debt Paydown
New CEO Robbert Rietbroek opened with a 30-day assessment and a clear reset: focus on operational fixes, tighter capex discipline, faster commercialization of innovation, and aggressive inventory redu...
- New CEO Robbert Rietbroek is running a 90-day review, emphasizing operational fixes, cost discipline, and faster commercialization of innovation after 30 days on the job.
- 2025 results: net sales ~$8.6 billion, adjusted EBITDA approximately $1.4 billion, fourth quarter adjusted EBITDA $311 million, adjusted EPS $1.80, ending net leverage 3.8x.
- 2026 guidance: net sales $8.4 billion to $8.6 billion, adjusted EBITDA guidance range $1.25 billion to $1.5 billion, normalized $1.2 billion to $1.4 billion, adjusted EPS $0.75 to $1.15.
- +12 more takeaways
Enterprise Products Partners Q4 2025 Earnings Call - Record $2.7B EBITDA; modest 2026, 10%+ growth expected in 2027 as NGL export and Permian ramps
Enterprise closed 2025 with a headline number investors love, a record fourth quarter adjusted EBITDA of $2.7 billion and a record near-$10 billion year for adjusted EBITDA. Management credited a stri...
- Record Q4 adjusted EBITDA of $2.7 billion, surpassing prior record, and near $10 billion adjusted EBITDA for full-year 2025.
- Net income attributable to common unit holders was $1.6 billion, or $0.75 per common unit, for Q4 2025.
- Adjusted cash flow from operations before working capital grew 5% to $2.4 billion in Q4 and reached a record $8.7 billion for 2025.
- +16 more takeaways
Patria Q4 2025 Earnings Call - Record Fundraising and Strategic M&A Push Fee-Earning AUM Toward $70B Goal
Patria closed 2025 with force, reporting a record $7.7 billion of organic fundraising, fee-related earnings of $203 million and distributable earnings of $200.9 million. Fee-earning AUM rose 24% year ...
- Record organic fundraising of $7.7 billion in 2025, well above the initial $6.0 billion target and the revised $6.6 billion midyear target.
- Fee-earning AUM ended Q4 at $40.8 billion, up 24% year over year; pro forma for announced acquisitions it is about $47.4 billion.
- Fee-related earnings (FRE) were $202.5 million for 2025, up 19% year over year, with Q4 FRE of $64.2 million and a Q4 FRE margin of roughly 63.6%.
- +13 more takeaways
ITW Q4 2025 Earnings Call - CBI and Enterprise Initiatives Push Margins to Record Levels, Guiding for Continued Expansion
ITW closed 2025 with a clean, operationally driven finish. Q4 total revenue rose 4.1% with organic up 1.3%, GAAP EPS improved 7% to $2.72, and companywide segment margins hit record levels as enterpri...
- Q4 total revenue grew 4.1%, comprised of organic growth of 1.3%, FX tailwind of 2.5%, and 0.3% from acquisitions.
- GAAP EPS in Q4 rose 7% to $2.72, and operating income was $1.1 billion, up 5% year over year.
- Companywide segment operating margin reached 27.7% in Q4, a 120 basis point improvement, with enterprise initiatives contributing roughly 140 basis points to that gain.
- +12 more takeaways
Ball Corporation Q4 2025 Earnings Call - Record EPS and FCF, 2026 Guidance Targets 10%+ Comparable EPS Despite $35M Headwinds
Ball closed out 2025 with one of its strongest years ever, reporting record comparable diluted EPS of $3.57 and record adjusted free cash flow of $956 million while returning $1.54 billion to sharehol...
- Record results: Comparable diluted EPS of $3.57 in 2025, up 13% year over year, and adjusted free cash flow of $956 million, a 2.4x increase versus 2024.
- Shareholder returns: Ball returned $1.54 billion in 2025 via $1.32 billion of buybacks and dividends; management plans at least $600 million of share repurchases in 2026, targeting 4% to 6% of shares annually.
- 2026 guidance: Company targets 10% plus comparable diluted EPS growth, free cash flow greater than $900 million, capex roughly in line with GAAP depreciation and amortization, and full year interest expense about $320 million.
- +12 more takeaways
Willis Towers Watson Q4 2025 Earnings Call - Margin expansion and strategic acquisitions drive 2026 momentum
WTW closed 2025 with steady organic growth and clear margin progress, reporting 6% organic growth in Q4 and 5% for the full year, adjusted operating margin up 130 basis points to 25.2% for the year, a...
- Q4 organic revenue growth was 6%, full year organic growth 5%, consistent with the company’s mid-single-digit target.
- Adjusted operating margin expanded 130 basis points year-over-year to 25.2% for FY2025; Q4 adjusted operating margin was 36.9%, up 80 basis points versus prior year.
- Adjusted diluted EPS was $17.08 for the year and $8.12 in Q4; excluding TRANZACT’s prior contribution, EPS rose about 13% year-over-year.
- +12 more takeaways
Galaxy Digital Q4 2025 Earnings Call - Helios approval doubles capacity to 1.6 GW, CoreWeave lease moves data centers into near-term revenue
This quarter was a tale of two businesses. The Helios data center play just went from promising to strategic, with ERCOT approving an incremental 830 MW and Galaxy now holding more than 1.6 GW of appr...
- Helios campus approved for more than 1.6 GW of power capacity after a subsequent ERCOT approval of 830 MW, more than doubling the campus footprint.
- 800 MW of capacity is contracted under the CoreWeave lease, and Galaxy expects to start recognizing revenue under that lease later in Q1 2026.
- Galaxy expects to deliver the first data halls by the end of Q1 2026 and complete the remaining phase one data halls (133 MW critical IT) within the first half of 2026; commissioning has begun and major components for the first hall are on site.
- +15 more takeaways
ATI Materials Q4 & Full Year 2025 Earnings Call - Guiding to $1.0B Adjusted EBITDA in 2026 on A&D Strength, LTAs and Targeted Nickel Capacity Build
ATI closed 2025 with clear momentum: Q4 revenue $1.2 billion and adjusted EBITDA $232 million, capping a $4.6 billion year where adjusted EBITDA exceeded $859 million and adjusted free cash flow rose ...
- Q4 revenue was $1.2 billion, adjusted EBITDA $232 million, and adjusted EBITDA margin 19.7%, up 180 basis points year over year for the quarter.
- Full-year 2025 revenue $4.6 billion, up 5% year over year; adjusted EBITDA exceeded $859 million, up 18% year over year.
- Adjusted EPS for 2025 was $3.24, up 32% versus 2024; adjusted free cash flow totaled $380 million, up 53% year over year.
- +12 more takeaways
Two Harbors Q4 2025 Earnings Call - Merger with UWM doubles MSR to $400B, signaling a scale-driven pivot
Two Harbors used its Q4 report to cast the UWM deal as a strategic inflection point, moving the firm from a niche MSR investor to a scale player. The company posted a solid quarter, with a +3.9% econo...
- Two Harbors announced a definitive merger with United Wholesale Mortgage, a deal that doubles pro forma MSR size to about $400 billion and stakes the company on scale as its principal strategic lever.
- Q4 total economic return was +3.9%, with book value up to $11.13 at December 31, versus $11.04 at September 30, including a $0.34 common dividend.
- Full-year 2025 economic return reported at -12.6%, which becomes +12.1% when excluding a previously recorded litigation settlement charge equal to $3.60 per share.
- +12 more takeaways